Final answer:
Management of CIN II/III during pregnancy generally involves conservative management with close follow-up. Surgical interventions are typically delayed until after childbirth, and vaginal delivery does not increase the risk of cervical trauma. Chemoradiation therapy is not recommended for managing CIN during pregnancy.
Step-by-step explanation:
Management of CIN II/III During Pregnancy:
The management of cervical intraepithelial neoplasia (CIN) II/III during pregnancy is a delicate balancing act between the health of the mother and the developing fetus. Typically, the recommendation is for conservative management with close follow-up. This means that the patient would undergo regular examinations and Pap smears to monitor any progression of the disease, but without immediate surgical intervention such as a cone biopsy or Loop Electrosurgical Excision Procedure (LEEP), which could potentially harm the fetus or lead to preterm labor.
Definitive treatment, including surgical removal of abnormal tissue, is usually postponed until after delivery unless there are highly concerning changes suggesting invasive cancer. Vaginal delivery is generally considered safe and does not contribute to cervical trauma in the context of CIN, although the specific mode of delivery should be discussed with an obstetrician. Chemoradiation therapy is not a treatment option for CIN II/III, but rather for more advanced stages of cervical cancer or when invasive cancer is present.